No. 19: Alcon
Fort Worth, Texas
2018 revenues: $7,149,000,000
Fiscal year ending: Dec. 31, 2018
Last year’s rank: 19
Key Personnel:
David Endicott, CEO; Laurent Attias, SVP, head global corp dev strategy, BD&L & M&A; Heather Attra, SVP, head global quality; Jeannette Bankes, president & GM, global surgical; Royce Bedward, SVP, GC & corporate secretary; Ian Bell, president, international; Sergio Duplan, president, North America; Sophie Dutilloy, president, EMEA; Camila Finzi, president, LACAR; Karen King, SVP, IR & communications; Franck Leveiller, SVP, head global R&D; Sue-Jean Lin, SVP, CIO; Roger Lopez, president, Japan; Merrick McCracken, SVP, head global HR; Ed McGough, SVP, head global manufacturing & technical operations; Rajkumar Narayanan, SVP, operational strategy & chief transformation officer; Michael Onuscheck, president, global business & innovation; Andy Pawson, president & GM, global vision care franchise; Tim Stonesifer, SVP, CFO
Description:
Novartis in April completed the spinout of its Alcon (NYSE:ALC) vision care business, which is now its own publicly traded company. “For more than 70 years, Alcon has been dedicated to helping people see brilliantly and now, as an independent company, we are pursuing even more opportunities to further that mission,” CEO David Endicott said in prepared remarks at the time. – CN